All right. Thank you.
With regard to the active personnel, the percentages are striking. At 5% of our current antimalarial prescriptions, mefloquine is now our least-selected medication, but in the overall evaluation of the medicine, would it be fair to say that it was a very low percentage of unanticipated extreme effects for the personnel who used it? Is that what the numbers tell us? That it is a low percentage of extreme effects?
I'm trying to extrapolate that from the material you've given us. How hard is this—
Go ahead.